Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentPreface
View the documentIntroduction
Open this folder and view contentsParasitic infections
Open this folder and view contentsInsect and arachnid bites and stings
Open this folder and view contentsSuperficial fungal infections
Open this folder and view contentsSubcutaneous fungal infections
Open this folder and view contentsBacterial infections
Open this folder and view contentsViral infections
Open this folder and view contentsEczematous diseases
Open this folder and view contentsScaling diseases
Open this folder and view contentsPapulosquamous diseases
View the documentCutaneous reactions to drugs
Open this folder and view contentsPigmentary disorders
Open this folder and view contentsPremalignant lesions and malignant tumours
Open this folder and view contentsPhotodermatoses
Open this folder and view contentsBullous dermatoses
View the documentAlopecia areata
View the documentUrticaria
Open this folder and view contentsConditions common in children
View the documentAcne vulgaris
View the documentPruritus
View the documentTropical ulcers
Open this folder and view contentsAntimicrobial drugs
Open this folder and view contentsAntifugal drugs
Open this folder and view contentsAntiseptic agents
Open this folder and view contentsKeratoplastic and keratolytic agents
Open this folder and view contentsScabicides and pediculicides
Open this folder and view contentsAnti-inflammatory and antipruritic drugs1
Open this folder and view contentsAntiallergics and drugs used in anaphylaxis
Open this folder and view contentsUltraviolet radiation-blocking agents (sunscreens)
Open this folder and view contentsMiscellaneous drugs
Open this folder and view contentsAnnex
View the documentSelected WHO Publications of Related Interest
View the documentBack cover
 

Preface

WHO’s revised drug strategy, as adopted in resolution WHA39.27 of the Thirty-ninth World Health Assembly in 1986, calls for the preparation of model prescribing information which is being developed to complement WHO’s Model List of Essential Drugs.1 The objective is to provide up-to-date source material for adaptation by national authorities, particularly in developing countries, that wish to develop national drug formularies, drug compendia and similar material.2

1The use of essential drugs Seventh report of the WHO Expert Committee Geneva, World Health Organization, 1997 (WHO Technical Report Series, No 867)

2 For details of volumes already published, see inside back cover

The information is to be regarded as illustrative rather than normative. It is appreciated that it is not possible to develop an information sheet on a specific drug that is appropriate to circumstances prevailing in each of WHO’s Member States and that some countries have already formally adopted texts of their own that have a statutory connotation.

This volume has been reviewed by internationally accredited experts and by certain nongovernmental organizations in official relations with WHO, including the International League of Dermatological Societies, the International Federation of Pharmaceutical Manufacturers Associations, the International Pharmaceutical Federation, the International Union of Pharmacology and the World Federation of Proprietary Medicine Manufacturers.

Drug dosage

Most drug doses are given per kilogram of body weight or as fixed doses calculated for adults of 60 kg.

Storage conditions

Readers are referred to The International Pharmacopoeia, 3rd edition, vol. 4 (Geneva, World Health Organization, 1994) for definitions concerning containers for drugs.

Abbreviations used

i.m. intramuscularly

i.v. intravenously

 

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019